Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers

Colloids and Surfaces B: Biointerfaces

Volumn 130, Issue , 2015, Pages 1-9

  Zhao, Xin ^a,b   Zhao, Jingwen ^a   Lin, Zhi Yuan William ^b   Pan, Guoqing ^a   Zhu, Yueqi ^c   Cheng, Yingsheng ^c   Cui, Wenguo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b HARVARD UNIVERSITY   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Electrospinning; Interfacial layer; Mesoporous silica nanoparticles; Polydopamine; Temporally controllable

Indexed keywords

CELL CULTURE; DRUG DELIVERY; DRUG PRODUCTS; ELECTROSPINNING; NANOPARTICLES; PLASTIC COATINGS; SCAFFOLDS (BIOLOGY); SILICA; TISSUE ENGINEERING; TUMORS;

ANTI-TUMOR ACTIVITIES; FIBROBLAST ADHESION; INTERFACIAL INTERACTION; INTERFACIAL LAYER; MESOPOROUS SILICA NANOPARTICLES; POLYDOPAMINE; TEMPORALLY CONTROLLABLE; TISSUE ENGINEERING SCAFFOLD;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; DRUG VEHICLE; IBUPROFEN; MESOPOROUS SILICA NANOPARTICLE; MOLECULAR SCAFFOLD; POLYDOPAMINE; POLYLACTIDE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; INDOLE DERIVATIVE; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYESTER; POLYMER; SILICON DIOXIDE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL PROLIFERATION; COMPARATIVE EFFECTIVENESS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG MIXTURE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPINNING; ENCAPSULATION; EXCIPIENT COMPATIBILITY; FIBROBLAST; HELA CELL LINE; IN VITRO STUDY; MACROPHAGE; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR RECURRENCE; 3T3 CELL LINE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN; MOUSE; POROSITY; PROCEDURES; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; IBUPROFEN; INDOLES; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NIH 3T3 CELLS; POLYESTERS; POLYMERS; POROSITY; SILICON DIOXIDE;

EID: 84927135427     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.03.058     Document Type: Article

References (33)

1. Gupta V., Mun G.H., Choi B., Aseh A., Mildred L., Patel A., Zhang Q., Price J.E., Chang D., Robb G., Mathur A.B. Repair and reconstruction of a resected tumor defect using a composite of tissue flap-nanotherapeutic-silk fibroin and chitosan scaffold. Biomed. Eng. 2011, 39:2374-2387.
2. Cole S.W.J. Chronic inflammation and breast cancer recurrence. Clin. Oncol. 2009, 27:3418-3419.
3. Luo X., Xie C., Wang H., Liu C., Yan S., Li X. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation. Int. J. Pharm. 2012, 425:19-28.
4. Chew S.Y., Wen Y., Dzenis Y., Leong K.W. The role of electrospinning in the emerging field of nanomedicine. Curr. Pharm. Des. 2006, 12:4751-4770.
5. Yang G., Wang J., Li L., Ding S., Zhou S. Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release. Macromol. Biosci. 2014, 14:965-976.
6. Song B., Wu C., Chang J. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. Acta Biomater. 2012, 8:1901-1907.
7. Song B., Wu C., Chang J. Controllable delivery of hydrophilic and hydrophobic drugs from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats. J. Biomed. Mater. Res. B 2012, 100:2178-2186.
8. Chen M., Zhu X., Yan D. Sequential drug release for synergistic cancer treatment and immunity promotion. RSC Adv. 2013, 3:13399-13405.
9. Ahmed A., Hearn J., Abdelmagid W., Zhang H. Dual-tuned drug release by nanofibrous scaffolds of chitosan and mesoporous silica microspheres. Mater. Chem. 2012, 22:25027-25035.
10. Qiu K., He C., Feng W., Wang W., Zhou X., Yin Z., Chen L., Wang H., Mo X. Doxorubicin-loaded electrospun poly(l-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment. J. Mater. Chem. B 2013, 1:4601-4611.
11. Kim Y.J., Ebara M., Aoyagi T. A smart hyperthermia nanofiber with switchable drug release for inducing cancer apoptosis. Adv. Funct. Mater. 2013, 23:5753-5761.
12. Okuda T., Tominaga K., Kidoaki S. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J. Control. Release 2010, 143:258-264.
13. Cui W., Li X., Zhu X., Yu G., Zhou S., Weng J. Investigation of drug release and matrix degradation of electrospun poly(dl-lactide) fibers with paracetamol inoculation. Biomacromolecules 2006, 7:1623-1629.
14. Liu J.J., Wang C.Y., Wang J.G., Ruan H.J., Fan C.Y. Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning. J. Biomed. Mater. Res. A 2011, 96A:13-20.
15. Kenawy E.R., Bowlin G.L., Mansfield K., Layman J., Simpson D.G., Sanders E.H., Wnek G.E. Release of tetracycline hydrochloride from electrospun poly(ethylene-covinylacetate), poly(lactic acid), and a blend. J. Control. Release 2002, 81:57-64.
16. Zheng F., Wang S., Shen M., Zhu M., Shi X. Antitumor efficacy of doxorubicin-loaded electrospun ano-hydroxyapatite-poly(lactic-co-glycolic acid) composite nanofibers. Polym. Chem. 2013, 4:933-941.
17. Jo E., Lee S., Kim K.T., Won Y.S., Kim H.-S., Cho E.C., Jeong U. Core-sheath nanofibers containing colloidal arrays in the core for programmable multi-agent delivery. Adv. Mater. 2009, 21:968-972.
18. Xu X., Chen X., Wang Z., Jing X. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur. J. Pharm. Biopharm. 2009, 72:18-25.
19. Kearns G.L., Wilson J.T., Hu C., Liu S., Zhang Y., Li B., Yang H., Fan C., Cui W. Determination of ibuprofen in serum by high-performance liquid chromatography and application to ibuprofen disposition. J. Chromatogr. B 1981, 226:183-190.
20. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69.
21. Zhao X., Hu C., Pan G., Cui W. Pomegranate-structured electrosprayed microspheres for long-term controlled drug release. Part. Part. Syst. Charact. 2014, 10.1002/ppsc.201400199.
22. Manzano M., Aina V., Areán C.O., Balas F., Cauda V., Colilla M., Delgado M.R., Vallet-Regi M. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chem. Eng. J. 2008, 137:30-37.
23. Dörner T., Haas J., Loddenkemper C., von Baehr V., Salama A. Implant-related inflammatory arthritis. Nat. Clin. Pract. Rheum. 2006, 2:53.
24. Sill T.J., von Recum H.A. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008, 29:1989-2006.
25. Sun X., Cheng L., Zhao J., Jin R., Sun B., Shi Y., Zhang Y.G., Cui W.G. bFGF-grafted electrospun fibrous scaffolds via poly(dopamine) for skin wound healing. J. Mater. Chem B. 2014, 2:3636-3645.
26. Yuan Z., Zhao X., Wang X., Qiu W., Chen X., Zheng Q., Cui W. Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes. Int. J. Clin. Exp. Pathol. 2014, 7:5436-5449.
27. Pillay V., Dott C., Choonara Y.E., Tyagi C., Tomar L.K., Kumar P., du Toit L., Ndesendo V.M.K. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J. Nanomater. 2013, 13:1-22.
28. Miao Y.E., Zhu H., Chen D., Wang R., Tjiu W.W., Liu T. Electrospun fibers of layered double hydroxide/biopolymer nanocomposites as effective drug delivery systems. Mater. Chem. Phys. 2012, 134:623-630.
29. Zomer Volpato F., Almodóvar J., Erickson K., Popat K.C., Migliaresi C., Kipper M.J. Preservation of FGF-2 bioactivity using heparin-based nanoparticles, and their delivery from electrospun chitosan fibers. Acta Biomater. 2012, 8:1551-1559.
30. Liu X., Liu S., Liu S., Cui W. Evaluation of oriented electrospun fibers for periosteal flap regeneration in biomimetic triphasic osteochondral implant. J. Biomed. Mater. Res. B 2014, 102:1407-1414.
31. Sombatmankhong K., Sanchavanakit N., Pavasant P., Supaphol P. Bone scaffolds from electrospun fiber mats of poly(3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and their blend. Polymer 2007, 48:1419-1427.
32. Shang S., Yang F., Cheng X., Walboomers X.F., Jansen J.A. The effect of electrospun fibre alignment on the behaviour of rat periodontal ligament cells. Eur. Cells Mater. 2010, 19:180-192.
33. Dahlin R.L., Kasper F.K., Mikos A.G. Polymeric nanofibers in tissue engineering. Tissue Eng. B-Rev. 2011, 17:349-364.